Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Alliance Boots

Alliance Boots, the Nottingham-based chain of 2,500 stores with 108,000 staff, is to be acquired by US-based Walgreens in a £9bn deal for the remaining 55%.

Alliance Boots has sold a 45% stake in its pharmacy and health business to Walgreens of the US for £4.3bn, creating a combined group of 11,000 stores in 12 countries.

Alliance Boots is considering plans to double the 500-strong workforce at its 460,000 sq ft distribution centre at Centrum 100 in Burton, having completed a £50m expansion project.

Alliance Boots is creating 50 jobs at its new BCM Specials bespoke medicines laboratory in Nottingham.

Alliance Boots is to merge Boots Opticians with Dollond & Aitchison to create a combined chain of 690 optical outlets with more than 5,000 staff.

Alliance Boots has acquired a 90% stake in Megapharm, the German oncology products supplier with 100 staff, for undisclosed terms.

Alliance Boots is to invest up to £1bn in capital expenditure for its health and beauty business over the next three years, and has also announced the transfer of its headquarters from Nottingham to Switzerland.

Alliance Boots has acquired HF Healthcare, the chain of 25 pharmacies in the north of England with 240 staff, for undisclosed terms.

Alliance Boots has acquired Henderson Pharmacy, the Northumberland-based chain of 14 pharmacies with 120 staff, for undisclosed terms.

Alliance Boots has agreed to a £11bn takeover offer from private equity firm Kohlberg Kravis Roberts, but there are not expected to be any job losses or store closures.

Alliance Boots is to invest £65m rebranding its 900 community pharmacies as "your local Boots pharmacy" over the next two years, and up to 100 stores will be closed or moved.

Alliance Boots is to set up a £3m Boots Centre for Innovation at Swansea University's Institute for Life Science, in order to help researchers and entrepreneurs develop new pharmaceutical products.